Clinical Trials Browser

Interventional × Breast Neoplasms × Blood Specimen Collection × Clear all

NCT06086704 2026-05-18

Study of 18F-FFNP Breast PET/MRI

Phase 2 Recruiting

Breast Neoplasms

NCT06274515 2026-05-06

REMERGE

Phase 4 Recruiting

Breast Neoplasms

NCT06127979 2026-05-05

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Phase NA Recruiting

Breast Neoplasms

NCT07555600 2026-04-29

E-FACTOR

Phase NA Not yet recruiting

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07490509 2026-04-01

DOSABEMA

Phase 4 Not yet recruiting

Breast Neoplasms

NCT04067726 2026-03-31

TRIDENT

Phase 2 Active not recruiting

Breast Neoplasms

NCT05981326 2026-03-31

NEOEPICURE

Phase NA Recruiting

Breast Neoplasms

NCT06435546 2026-03-27

AdOTAC

Phase NA Completed

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT05595577 2026-03-20

PALS

Phase NA Recruiting

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT00911911 2026-03-13

SPAM

Phase NA Completed

Breast Neoplasms

NCT03249389 2026-03-12

CALCIOBS

Phase NA Completed

Breast Neoplasms

NCT03252912 2026-03-12

LCS Bio Sein

Phase NA Completed

Breast Neoplasms

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT07236177 2026-02-05

B-GLUCANCER2

Phase EARLY_PHASE1 Recruiting

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT04530890 2025-12-24

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms

NCT06273800 2025-11-26

Chemosense

Phase NA Recruiting

Breast Neoplasms

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT07084558 2025-10-28

TEODOR

Phase NA Recruiting

Breast Neoplasms

NCT02831634 2025-09-08

NeoEpitope

Phase NA Completed

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06896162 2025-07-11

PROGRESS

Phase NA Recruiting

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT02662621 2025-06-05

EXODIAG

Phase NA Completed

BreastGynecologicThoracic

Breast Neoplasms, Disease, Lung Neoplasms, Neoplasms, Ovarian Neoplasms

NCT04054986 2025-05-16

Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer

Phase 1 Completed

Breast Neoplasms

NCT03252717 2025-04-02

BIORISE

Phase NA Active not recruiting

Breast Neoplasms

NCT04025541 2025-04-02

ALCINA2

Phase NA Recruiting

BreastCNSGastrointestinalSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Glioma, Lung Neoplasms, Neoplasms, Sarcoma

NCT05899387 2025-02-28

SerMa

Phase NA Recruiting

Breast Neoplasms, Seroma

NCT01186367 2025-02-10

Excite

Phase NA Completed

174 enrolled 11 charts

Breast Neoplasms

NCT05303129 2025-01-20

PEPSI

Phase NA Completed

Breast Neoplasms

NCT04104633 2025-01-13

Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the "Massive Parallel Sequencing" on Circulating Tumor DNA

Phase NA Completed

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms

NCT01993498 2024-10-18

CANTO

Phase NA Recruiting

14,750 enrolled

Breast Neoplasms, Lung Neoplasms

NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT05898009 2024-08-22

CanSeR-OGen

Phase NA Recruiting

Breast Neoplasms, Genetic Diseases, Inborn

NCT04531696 2024-06-28

UPTIDER

Phase NA Recruiting

Breast Neoplasms, Genetic Diseases, Inborn

NCT04925856 2023-10-17

IMMUNE CAPTURE

Phase NA Recruiting

Breast Neoplasms

NCT01725633 2023-04-06

Breast Mets

Phase NA Completed

Breast Neoplasms

NCT04781062 2022-11-01

RENOVATE

Phase NA Unknown

Breast Neoplasms

NCT04948840 2022-06-23

TREM-1

Phase NA Unknown

Breast Neoplasms, Fibrosis, Radiation Injuries

NCT02696759 2022-03-16

Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer

Phase NA Terminated

15 enrolled 6 charts

Breast Neoplasms, Neoplasms

NCT02907918 2021-09-29

PALTAN

Phase 2 Terminated

26 enrolled 8 charts

Breast Neoplasms

NCT03787056 2021-07-16

ONCOPRO

Phase NA Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, B-Cell, Endometrial Neoplasms

NCT04729647 2021-02-02

Immature Granulocyte Count and Delta Neutrophil Index Factors for Axillary Metastasis of Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT01440413 2020-03-24

BREAST IMMUN

Phase NA Unknown

Breast Neoplasms, Recurrence

NCT01263613 2019-11-19

Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT03262831 2019-09-03

Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT02613923 2019-05-09

A Sleep Intervention to Improve Outcomes Among Women at High Risk of Breast Cancer

Phase NA Completed

Breast Neoplasms

NCT01460186 2019-01-15

StoRM

Phase NA Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00651976 2018-10-15

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Phase EARLY_PHASE1 Terminated

Breast Neoplasms

NCT03000764 2018-08-08

SPLICI-Rad

Phase NA Completed

Breast Neoplasms, Fibrosis

NCT02523612 2018-07-24

NOMAT01

Phase NA Completed

Breast Neoplasms

NCT03567044 2018-06-25

Immune Effects in Patients Treated With Whole Breast Irradiation

Phase NA Unknown

Breast Neoplasms

NCT03401359 2018-01-17

The Resistance and Immune Response to Palbociclib in Breast Cancer

Phase NA Unknown

Breast Neoplasms